Portable Potency Testing for Production Control: Build a ‘Good Enough’ Method You Can Defend

Why portable potency testing matters (and what it is not)

Extraction leaders don’t need another dashboard—they need fast, defensible decisions when a run is moving and money is burning. A portable HPLC potency testing workflow can give you actionable signal in minutes so you can adjust parameters, choose cuts, hit blend targets, and prevent off-spec product from moving downstream.

At the same time, your internal in-process results are not automatically a compliance certificate of analysis (COA). COAs typically require an accredited lab scope, validated methods, proficiency testing, controlled chain-of-custody, and jurisdiction-specific reporting rules. Your goal for portable testing is different:

• Purpose: In-process control (IPC)—make production decisions quickly.
• Standard: Fit-for-purpose method verification and transparent limitations.
• Output: Decision support (cuts, rework, blend math, hold/release pending third-party results).

If you frame it this way, you can build a “good enough” method that stands up internally and holds up under reasonable scrutiny from QA, auditors, partners, and (most importantly) your own post-mortems.

Recommended gear for this approach: Orange Photonics LightLab 3 Cannabis Analyzer (portable HPLC)

• Product page: https://www.urthandfyre.com/equipment-listings/orange-photonics-lightlab-3-cannabis-analyzer---potency-testing-lab-
• Listing slug CTA: https://www.urthandfyre.com/equipment-listings/orange-photonics-lightlab-3-cannabis-analyzer---potency-testing-lab-

---

What “defensible IPC” means in practice

A defensible IPC program answers four questions clearly:

1. What decision does this test support? (Example: “Choose heads/hearts/tails cut points,” “Confirm distillate potency before formulation,” “Verify blend target before fill.”)
2. What performance is required for that decision? (Example: “Within ±10% relative of true value is sufficient to avoid a rework loop.”)
3. How do we control the measurement system day-to-day? (Calibration/verification, controls, replicates.)
4. How do we protect data integrity and document limitations? (Access control, audit trail basics, backups, deviation handling.)

If you can articulate those four elements, you can defend why the method is appropriate for IPC even if it is not positioned as a regulatory COA.

---

Start with a tight use-case: decisions you must make today

Portable potency testing succeeds when it is tied to specific control points. Common IPC use-cases:

1) Distillation cut decisions

• Decision: When to transition between cut fractions (and whether to recombine).
• Signal needed: Relative changes in major cannabinoids and/or target analytes.
• Risk: Over-trusting a single data point and chasing noise.

2) Blend-to-target before downstream work

• Decision: Blend lots to hit a potency target (and manage minor cannabinoid specs).
• Signal needed: Potency estimate with defined uncertainty to compute blend ratios.

3) Release holds / routing

• Decision: Hold, rework, or route material to a different SKU while waiting on third-party COA.
• Signal needed: High confidence that you’re not sending obviously off-target material forward.

4) Troubleshooting yield loss or unexpected potency drift

• Decision: Identify where potency is being lost (process step, operator practice, or sampling).
• Signal needed: Repeatable comparisons at the same IPC point over time.

Write these decisions into your SOP first. Your method requirements flow from the decision.

---

The portable analyzer: what to validate vs what to verify

Most production teams don’t need to run a full ICH-style validation package to get value. For IPC you typically implement method verification—prove the system performs adequately for your intended use.

A practical path:

• Vendor validation evidence: Leverage manufacturer materials and studies (e.g., repeatability/reproducibility work). Orange Photonics has published LightLab 3 repeatability & reproducibility summaries using ASTM E691-style calculations (useful context for expected performance). Source: https://www.orangephotonics.com/wp-content/uploads/Executive-Summaries_LightLab-3-Repeatability-Reproducibility-Studies.pdf
• Your verification: Confirm performance with your matrices, your operators, your environment, and your decision thresholds.

Also keep an eye on recognized performance guidance like AOAC SMPRs (Standard Method Performance Requirements) for cannabinoid quantitation across matrices (plant material, concentrates, beverages). These documents are useful for benchmarking what “good” analytical performance looks like even if your IPC method doesn’t aim to meet every COA requirement.

Examples:

• AOAC SMPR 2017.001 (concentrates): https://www.aoac.org/wp-content/uploads/2020/11/SMPR202017_001.pdf
• AOAC SMPR 2019.003 (low-THC hemp plant materials): https://www.aoac.org/wp-content/uploads/2020/11/SMPR202019_003.pdf
• AOAC SMPR 2022.001 (beverages): https://www.aoac.org/wp-content/uploads/2022/11/SMPR-2022_001.pdf

---

A “defensible IPC” framework you can implement in 30 days

Step 1: Define acceptance criteria that match the decision

IPC acceptance criteria must be decision-linked, not aspirational.

Examples (illustrative—set yours based on risk):

• Cut transition: If the estimate shifts by ≥X% (relative) compared to the prior fraction, change cut. If change is within noise band, keep running.
• Blend math: Only blend based on IPC result when replicate RSD is below Y% and the control sample is within limits.
• Release routing: If IPC shows potency below internal floor, automatically hold for rework; if above floor and within blendable band, route to formulation while awaiting third-party COA.

Document these rules explicitly so operators aren’t forced to “interpret.”

Step 2: Build a calibration + verification cadence

Portable instruments often have guided calibration routines, but for defensibility you want a routine that is both easy and consistent.

Use a three-layer model:

Layer A — Per shift: quick system suitability / verification

• Run a known check standard or control material at the start of each shift (or each run block).
• Confirm it lands within your predefined control limits.
• If it fails: stop, troubleshoot, recalibrate, and document.

Layer B — Daily/weekly: matrix control checks

Because matrices drive error, add matrix-relevant checks:

• Concentrate-style control (high potency, viscous)
• Beverage/emulsion control (if you do those)

AOAC beverage guidance emphasizes that detailed and reproducible sample preparation procedures must be addressed by matrix—treat that as a warning label for IPC as well. Source: https://www.aoac.org/wp-content/uploads/2022/11/SMPR-2022_001.pdf

Layer C — Monthly/quarterly: third-party cross-check

• Pick representative lots and send splits to a third-party lab.
• Compare your IPC results to the external COA trendline.
• Track bias and adjust your internal decision thresholds if needed.

This is the most powerful way to keep portable data aligned with reality without pretending it replaces compliance testing.

Step 3: Control samples: the heart of defensible IPC

You need at least two types of controls.

1) Calibration/verification standard

• A stable standard at a known level, ideally traceable.
• Used to verify the instrument is behaving.

2) In-house control material (IHC)

• A retained, well-mixed material similar to your production matrix.
• Used to detect drift due to sample prep, matrix effects, or operator variation.

How to set control limits:

• Run 10–20 measurements over multiple days/operators.
• Calculate mean and standard deviation.
• Set alert/action limits (e.g., ±2 SD alert, ±3 SD action) appropriate to risk.

Don’t overcomplicate: the goal is to know when your system is lying to you.

Step 4: Replicate strategy (don’t treat one-off readings as truth)

One of the biggest pitfalls in portable testing is believing a single number.

A pragmatic replicate policy:

• Routine IPC: 2 replicates per sample.
• If replicates differ by more than a preset threshold (e.g., >10% relative difference), run a 3rd replicate.
• Use the mean of acceptable replicates.
• If still inconsistent: treat as a sampling/sample prep failure, not a process shift.

This gives you speed while still resisting noise.

Step 5: Sample prep SOPs that are matrix-specific (where most error lives)

Most potency “disagreements” are not instrument problems—they’re sampling and prep problems.

Concentrates and viscous oils

Key risks: poor homogenization, incomplete dissolution, dilution errors, and carryover.

Practical controls:

• Warm viscous material consistently (define temperature/time window).
• Homogenize mechanically where possible (vortex, bead-based mixing, or controlled stirring) before taking an aliquot.
• Use consistent solvents and dilution ratios.
• Use high-quality pipettes/tips and confirm pipette performance on a schedule.

Beverages, emulsions, and syrups

Key risks: phase separation, adsorption to plastics, inconsistent sampling depth, and unstable emulsions.

Practical controls:

• Define mixing method and time (shake vs stir vs vortex).
• Sample immediately after mixing within a defined window.
• Use appropriate containers that reduce adsorption.

Solid or semi-solid intermediates

Key risks: heterogeneity and “hot spots.”

Practical controls:

• Take multiple increments and composite.
• Grind/mill if appropriate and permitted.
• Homogenize before aliquoting.

General guidance from multiple lab resources emphasizes homogenization as a first-order requirement for potency testing. For an overview-style reference, see Restek’s potency testing primer emphasizing sample homogeneity and preparation discipline: https://discover.restek.com/blogs/gnbl5521/new-to-cannabis-potency-testing-click-here

Step 6: Document limitations transparently

Defensibility improves when you clearly state what the method can’t do.

Include a short “Limitations” section in your SOP and in reports:

• Intended use is IPC decision-making, not regulatory COA.
• Method is verified for specific matrices (list them) and specific potency ranges.
• Results may differ from third-party COAs due to method differences, matrix effects, and sample handling.
• Define what triggers a mandatory external lab test (e.g., new product type, new matrix, new supplier, process upset, customer complaint).

This is how you avoid the trap of accidentally marketing internal data as compliance truth.

---

Data integrity for production teams (simple, practical, non-negotiable)

You don’t need a full LIMS rollout to be disciplined, but you do need to prevent “spreadsheet chaos.” Use Part 11-style thinking in a right-sized way.

FDA’s Part 11 regulation and guidance are aimed at electronic records and signatures; even when not strictly required, the principles are valuable: access control, audit trails, record retention, and the ability to produce complete copies. References:

• 21 CFR Part 11 (eCFR): https://www.ecfr.gov/current/title-21/chapter-I/subchapter-A/part-11
• FDA guidance on scope and application: https://www.fda.gov/media/75414/download

Minimum viable controls for portable potency testing

1) User access control

• Unique user IDs (no shared logins).
• Role-based permissions: Operator vs Supervisor vs Admin.
• Quarterly access review (remove ex-employees, contractors).

2) Audit trail basics

• Ensure the system records who ran what, when, and any reprocessing/edits.
• If the platform doesn’t support full audit trails, compensate procedurally:
• Controlled worksheets
• Supervisor review sign-off
• Immutable exports (PDF) at time of test

3) Secure backups

• Automatic backup to a controlled location (company-managed cloud drive or server).
• Define retention time (e.g., aligned to your quality record retention policy).
• Test restore at least annually.

4) Training and accountability

• Train on sample prep, instrument handling, and data handling.
• Require documentation of deviations (missed controls, re-runs, failed checks).

These steps keep IPC data usable when you need to explain an outcome months later.

---

Cost-per-sample and ROI: where portable wins (and where it doesn’t)

Portable potency testing ROI is usually driven by avoided delays and prevented rework, not simply cheaper assays.

Where you typically win:

• Fewer “wait-and-hope” holds while material sits.
• Faster tuning of cuts and parameters (less off-target fraction volume).
• Better blend math (less give-away and fewer potency surprises).
• Earlier detection of process drift (less downstream scrap).

Where you should be cautious:

• If you try to replace all third-party testing, you may increase risk.
• If you don’t control sample prep and replicates, your false confidence cost will exceed assay savings.

A good KPI set to track after implementation:

• Cycle time reduction (hours saved per batch)
• Rework rate reduction
• Potency variability (standard deviation lot-to-lot)
• Number of lots prevented from entering packaging/formulation off-target

---

Common pitfalls (and how to avoid them)

Pitfall 1: Treating one-off readings as the truth

Fix:

• Implement the replicate strategy and control limits.
• Require a reason code for single-replicate “rush” tests.

Pitfall 2: Poor homogenization

Fix:

• Write matrix-specific homogenization steps.
• Use composite sampling where heterogeneity is likely.
• Audit homogenization technique during training.

Pitfall 3: Skipping matrix-specific sample prep

Fix:

• Create separate SOP appendices for each matrix.
• Verify each matrix separately.

Pitfall 4: No cross-check to external labs

Fix:

• Schedule monthly/quarterly split-sample comparisons.
• Trend bias and adjust decision thresholds.

Pitfall 5: Weak data integrity

Fix:

• Lock down access, standardize naming, back up automatically, and define review.

---

How Urth & Fyre helps you implement a portable HPLC potency testing workflow

Buying the instrument is the easy part. The value comes from the workcell, the SOPs, and the governance.

Urth & Fyre can help teams with:

• Workcell setup: bench layout, solvent handling practices, labeling, staging, waste management, and a clean flow that reduces mix-ups.
• Training: operator training on sampling, matrix prep, replicate rules, and how to interpret IPC results without overclaiming.
• Verification package: control material plan, verification runs, acceptance criteria tied to decisions, and deviation handling.
• Cross-check alignment: a standing plan to compare IPC to third-party COAs and trend instrument/operator performance.

If you’re evaluating portable potency testing equipment, start with the listing here:

Orange Photonics LightLab 3 Cannabis Analyzer - Potency Testing (HPLC)

• https://www.urthandfyre.com/equipment-listings/orange-photonics-lightlab-3-cannabis-analyzer---potency-testing-lab-

For more QA/QC and production equipment listings, explore the marketplace at https://www.urthandfyre.com.

---

Implementation timeline (a realistic 4-week rollout)

Week 1: Define the decision points

• Map 3–5 IPC points.
• Write decision rules and acceptance criteria.

Week 2: Build the sample prep appendices

• Concentrate vs beverage vs other matrices.
• Train two operators.

Week 3: Establish controls and replicate rules

• Run baseline control data.
• Set alert/action limits.

Week 4: Start operating + schedule cross-checks

• Go live for IPC.
• Send the first split samples to an external lab.
• Review results and adjust thresholds.

---

Bottom line

A portable analyzer can be a force multiplier for extraction and production control when you treat it as IPC—not as a substitute for compliance COAs. Build a defensible program by tying acceptance criteria to decisions, using controls and replicates to manage uncertainty, enforcing matrix-specific sample prep, and implementing lightweight but real data integrity.

To explore equipment listings and get help designing an IPC workcell and verification plan, visit https://www.urthandfyre.com.